Reuters logo
BRIEF-Imprimis Pharmaceuticals enters into agreements with two accredited investors
March 22, 2017 / 12:12 PM / 6 months ago

BRIEF-Imprimis Pharmaceuticals enters into agreements with two accredited investors

March 22 (Reuters) - Imprimis Pharmaceuticals Inc

* Has entered into agreements with two accredited investors

* Agreements for a registered direct placement of 1.3 million shares of common stock at a price of $2.40 per share

* National Securities Corporation, a unit of National Holdings acted as exclusive placement agent for offering Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below